33P Impact of prior treatment on baseline immune biomarkers and nivolumab + relatlimab (NIVO+RELA)-induced changes in the tumor microenvironment (TME) in patients (pts) with melanoma from RELATIVITY-020

Autor: Ascierto, P.A., Tang, H., Dolfi, S., Nyakas, M.S., Svane, I-M., Couselo, E. Muñoz, Grob, J.J., Gomez-Roca, C.A., Sileni, V. Chiarion, Peltola, K., Larkin, J., Melero, I., Callahan, M., Dummer, R., Djidel, P., Warad, D., Lipson, E.J., Garnett-Benson, C.
Zdroj: In Immuno-Oncology and Technology December 2023 20 Supplement
Databáze: ScienceDirect